Global Troponin Diagnostic Tests Market
Global Troponin Diagnostic Tests Market

Troponin Diagnostic Tests Comprehensive Study by Type (Troponin I ELISA Test, Troponin Rapid test), Sales Channels (Online Sales Channel {Company Website, E-Commerce Platform}, Offline Sales Channels {Company store outlet, Hypermarket, and medical Stores}), Technology (Qualitative Cardiac Troponin I Rapid Test (Qualitative cTnI), Semi-Quantitative Cardiac Troponin I Rapid Test (Semi-Quantitative cTnI), Quantitative Cardiac Troponin I Rapid Test (Quantitative cTnI)) Players and Region - Global Market Outlook to 2026

Troponin Diagnostic Tests Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Nov 2021 Edition 222 Pages 180 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Troponin Diagnostic Tests Market Scope?
A troponin test is to measures the level of troponin in blood. A protein found in the muscles of your heart, which isn't normally found in the blood. Troponin is sent into the bloodstream when heart muscles become damaged. This test is most prominently used to diagnose a heart attack. Along with this also used to monitor angina, which limits blood flow to the heart and causes chest pain. It has been estimated that 840,000 Americans die of cardiovascular diseases each year. In 2017 Food and Drug Administration (FDA) approved since then many laboratories in the U.S. used high-sensitivity troponin tests.

The Troponin Diagnostic Tests market study is being classified by Type (Troponin I ELISA Test and Troponin Rapid test) and major geographies with country level break-up.

Major manufacturers of the products are well-established pharma companies and they are mainly focusing on the research and development of the products like up-gradation of testing kit 4th generation to 5th generation which is more accurate, can detect a fraction of fluctuations in troponin. Although the leading pharma companies focusing on more acquisitions of the small scale companies to reach out. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Troponin Diagnostic Tests market throughout the predicted period.

Abbott Diagnostics, Inc. (United States.), F. Hoffmann-La Roche Ltd (Switzerland), BioMrieux SA (France), BG Medicine, Inc. (United States), Singulex, Inc. (United States), Alere, Inc. (United States), Siemens Healthcare Diagnostics, Inc. (Germany), Beckman Coulter, Inc. (United States), LifeSign LLC (United States) and Danaher Corporation (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Thermo Fisher Scientific, Inc. (United States), Bio-Rad Laboratories, Inc. (United States) and Ortho-Clinical Diagnostics, Inc. (India).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Troponin Diagnostic Tests market by Type, Application and Region.

On the basis of geography, the market of Troponin Diagnostic Tests has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

In Feb 2021, Psyros Diagnostics announced the development of ultra-sensitive, ultra-fast, point of care diagnostics based on single molecue counting. The company get grant of around Euro 99,400 by NHSEI SBRI Healthcare. Under this ememrgency grants, the company produced a prototype of its troponin diagnostic test system.


Influencing Market Trend
  • High sensitivity troponin test kits products

Market Drivers
  • By application, the global troponin market is driven into acute coronary syndrome, myocardial infarction, which is a leading application of troponin

Opportunities
  • Developmental opportunities for Troponin diagnostic kits are majorly in prize of the kit, home testing kits and availability of the kit

Restraints
  • Major restraints for troponin diagnostic kits was observed that 68% of test kits used for the diagnosis of physically injured patients, followed by older people

Challenges
  • Time taking process creates many challenges to lower-sensitivity troponin assays


Key Target Audience
Hospitals, Medical Institutes and Pathology Labs

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Frequently Asked Questions (FAQ):

1. At what growth rate would the Troponin Diagnostic Tests market expands?
The Global Troponin Diagnostic Tests market is expected to see a growth of % during projected year 2020 to 2026.

2. Who are the prominent players of the Global Troponin Diagnostic Tests market?
The prominent players of Global Troponin Diagnostic Tests market are Abbott Diagnostics, Inc. (United States.), F. Hoffmann-La Roche Ltd (Switzerland), BioMrieux SA (France), BG Medicine, Inc. (United States), Singulex, Inc. (United States), Alere, Inc. (United States), Siemens Healthcare Diagnostics, Inc. (Germany), Beckman Coulter, Inc. (United States), LifeSign LLC (United States) and Danaher Corporation (United States), to name a few.

3. What are the top priorities to focus for Troponin Diagnostic Tests marketís growth?
In this highly competitive & fast evolving Troponin Diagnostic Tests industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.
Report Objectives / Segmentation Covered
By Type
  • Troponin I ELISA Test
  • Troponin Rapid test
By Sales Channels
  • Online Sales Channel {Company Website, E-Commerce Platform}
  • Offline Sales Channels {Company store outlet, Hypermarket, and medical Stores}

By Technology
  • Qualitative Cardiac Troponin I Rapid Test (Qualitative cTnI)
  • Semi-Quantitative Cardiac Troponin I Rapid Test (Semi-Quantitative cTnI)
  • Quantitative Cardiac Troponin I Rapid Test (Quantitative cTnI)

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. By application, the global troponin market is driven into acute coronary syndrome, myocardial infarction, which is a leading application of troponin
    • 3.3. Market Challenges
      • 3.3.1. Time taking process creates many challenges to lower-sensitivity troponin assays
    • 3.4. Market Trends
      • 3.4.1. High sensitivity troponin test kits products
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Troponin Diagnostic Tests, by Type, Sales Channels, Technology and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Troponin Diagnostic Tests (Value)
      • 5.2.1. Global Troponin Diagnostic Tests by: Type (Value)
        • 5.2.1.1. Troponin I ELISA Test
        • 5.2.1.2. Troponin Rapid test
      • 5.2.2. Global Troponin Diagnostic Tests by: Sales Channels (Value)
        • 5.2.2.1. Online Sales Channel {Company Website, E-Commerce Platform}
        • 5.2.2.2. Offline Sales Channels {Company store outlet, Hypermarket, and medical Stores}
      • 5.2.3. Global Troponin Diagnostic Tests by: Technology (Value)
        • 5.2.3.1. Qualitative Cardiac Troponin I Rapid Test (Qualitative cTnI)
        • 5.2.3.2. Semi-Quantitative Cardiac Troponin I Rapid Test (Semi-Quantitative cTnI)
        • 5.2.3.3. Quantitative Cardiac Troponin I Rapid Test (Quantitative cTnI)
      • 5.2.4. Global Troponin Diagnostic Tests Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Australia
          • 5.2.4.2.6. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Troponin Diagnostic Tests (Price)
      • 5.3.1. Global Troponin Diagnostic Tests by: Type (Price)
  • 6. Troponin Diagnostic Tests: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Diagnostics, Inc. (United States.)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. F. Hoffmann-La Roche Ltd (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. BioMrieux SA (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. BG Medicine, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Singulex, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Alere, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Siemens Healthcare Diagnostics, Inc. (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Beckman Coulter, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. LifeSign LLC (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Danaher Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Troponin Diagnostic Tests Sale, by Type, Sales Channels, Technology and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Troponin Diagnostic Tests (Value)
      • 7.2.1. Global Troponin Diagnostic Tests by: Type (Value)
        • 7.2.1.1. Troponin I ELISA Test
        • 7.2.1.2. Troponin Rapid test
      • 7.2.2. Global Troponin Diagnostic Tests by: Sales Channels (Value)
        • 7.2.2.1. Online Sales Channel {Company Website, E-Commerce Platform}
        • 7.2.2.2. Offline Sales Channels {Company store outlet, Hypermarket, and medical Stores}
      • 7.2.3. Global Troponin Diagnostic Tests by: Technology (Value)
        • 7.2.3.1. Qualitative Cardiac Troponin I Rapid Test (Qualitative cTnI)
        • 7.2.3.2. Semi-Quantitative Cardiac Troponin I Rapid Test (Semi-Quantitative cTnI)
        • 7.2.3.3. Quantitative Cardiac Troponin I Rapid Test (Quantitative cTnI)
      • 7.2.4. Global Troponin Diagnostic Tests Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Australia
          • 7.2.4.2.6. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Troponin Diagnostic Tests (Price)
      • 7.3.1. Global Troponin Diagnostic Tests by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Troponin Diagnostic Tests: by Type(USD Million)
  • Table 2. Troponin Diagnostic Tests Troponin I ELISA Test , by Region USD Million (2015-2020)
  • Table 3. Troponin Diagnostic Tests Troponin Rapid test , by Region USD Million (2015-2020)
  • Table 4. Troponin Diagnostic Tests: by Sales Channels(USD Million)
  • Table 5. Troponin Diagnostic Tests Online Sales Channel {Company Website, E-Commerce Platform} , by Region USD Million (2015-2020)
  • Table 6. Troponin Diagnostic Tests Offline Sales Channels {Company store outlet, Hypermarket, and medical Stores} , by Region USD Million (2015-2020)
  • Table 7. Troponin Diagnostic Tests: by Technology(USD Million)
  • Table 8. Troponin Diagnostic Tests Qualitative Cardiac Troponin I Rapid Test (Qualitative cTnI) , by Region USD Million (2015-2020)
  • Table 9. Troponin Diagnostic Tests Semi-Quantitative Cardiac Troponin I Rapid Test (Semi-Quantitative cTnI) , by Region USD Million (2015-2020)
  • Table 10. Troponin Diagnostic Tests Quantitative Cardiac Troponin I Rapid Test (Quantitative cTnI) , by Region USD Million (2015-2020)
  • Table 11. South America Troponin Diagnostic Tests, by Country USD Million (2015-2020)
  • Table 12. South America Troponin Diagnostic Tests, by Type USD Million (2015-2020)
  • Table 13. South America Troponin Diagnostic Tests, by Sales Channels USD Million (2015-2020)
  • Table 14. South America Troponin Diagnostic Tests, by Technology USD Million (2015-2020)
  • Table 15. Brazil Troponin Diagnostic Tests, by Type USD Million (2015-2020)
  • Table 16. Brazil Troponin Diagnostic Tests, by Sales Channels USD Million (2015-2020)
  • Table 17. Brazil Troponin Diagnostic Tests, by Technology USD Million (2015-2020)
  • Table 18. Argentina Troponin Diagnostic Tests, by Type USD Million (2015-2020)
  • Table 19. Argentina Troponin Diagnostic Tests, by Sales Channels USD Million (2015-2020)
  • Table 20. Argentina Troponin Diagnostic Tests, by Technology USD Million (2015-2020)
  • Table 21. Rest of South America Troponin Diagnostic Tests, by Type USD Million (2015-2020)
  • Table 22. Rest of South America Troponin Diagnostic Tests, by Sales Channels USD Million (2015-2020)
  • Table 23. Rest of South America Troponin Diagnostic Tests, by Technology USD Million (2015-2020)
  • Table 24. Asia Pacific Troponin Diagnostic Tests, by Country USD Million (2015-2020)
  • Table 25. Asia Pacific Troponin Diagnostic Tests, by Type USD Million (2015-2020)
  • Table 26. Asia Pacific Troponin Diagnostic Tests, by Sales Channels USD Million (2015-2020)
  • Table 27. Asia Pacific Troponin Diagnostic Tests, by Technology USD Million (2015-2020)
  • Table 28. China Troponin Diagnostic Tests, by Type USD Million (2015-2020)
  • Table 29. China Troponin Diagnostic Tests, by Sales Channels USD Million (2015-2020)
  • Table 30. China Troponin Diagnostic Tests, by Technology USD Million (2015-2020)
  • Table 31. Japan Troponin Diagnostic Tests, by Type USD Million (2015-2020)
  • Table 32. Japan Troponin Diagnostic Tests, by Sales Channels USD Million (2015-2020)
  • Table 33. Japan Troponin Diagnostic Tests, by Technology USD Million (2015-2020)
  • Table 34. India Troponin Diagnostic Tests, by Type USD Million (2015-2020)
  • Table 35. India Troponin Diagnostic Tests, by Sales Channels USD Million (2015-2020)
  • Table 36. India Troponin Diagnostic Tests, by Technology USD Million (2015-2020)
  • Table 37. South Korea Troponin Diagnostic Tests, by Type USD Million (2015-2020)
  • Table 38. South Korea Troponin Diagnostic Tests, by Sales Channels USD Million (2015-2020)
  • Table 39. South Korea Troponin Diagnostic Tests, by Technology USD Million (2015-2020)
  • Table 40. Australia Troponin Diagnostic Tests, by Type USD Million (2015-2020)
  • Table 41. Australia Troponin Diagnostic Tests, by Sales Channels USD Million (2015-2020)
  • Table 42. Australia Troponin Diagnostic Tests, by Technology USD Million (2015-2020)
  • Table 43. Rest of Asia-Pacific Troponin Diagnostic Tests, by Type USD Million (2015-2020)
  • Table 44. Rest of Asia-Pacific Troponin Diagnostic Tests, by Sales Channels USD Million (2015-2020)
  • Table 45. Rest of Asia-Pacific Troponin Diagnostic Tests, by Technology USD Million (2015-2020)
  • Table 46. Europe Troponin Diagnostic Tests, by Country USD Million (2015-2020)
  • Table 47. Europe Troponin Diagnostic Tests, by Type USD Million (2015-2020)
  • Table 48. Europe Troponin Diagnostic Tests, by Sales Channels USD Million (2015-2020)
  • Table 49. Europe Troponin Diagnostic Tests, by Technology USD Million (2015-2020)
  • Table 50. Germany Troponin Diagnostic Tests, by Type USD Million (2015-2020)
  • Table 51. Germany Troponin Diagnostic Tests, by Sales Channels USD Million (2015-2020)
  • Table 52. Germany Troponin Diagnostic Tests, by Technology USD Million (2015-2020)
  • Table 53. France Troponin Diagnostic Tests, by Type USD Million (2015-2020)
  • Table 54. France Troponin Diagnostic Tests, by Sales Channels USD Million (2015-2020)
  • Table 55. France Troponin Diagnostic Tests, by Technology USD Million (2015-2020)
  • Table 56. Italy Troponin Diagnostic Tests, by Type USD Million (2015-2020)
  • Table 57. Italy Troponin Diagnostic Tests, by Sales Channels USD Million (2015-2020)
  • Table 58. Italy Troponin Diagnostic Tests, by Technology USD Million (2015-2020)
  • Table 59. United Kingdom Troponin Diagnostic Tests, by Type USD Million (2015-2020)
  • Table 60. United Kingdom Troponin Diagnostic Tests, by Sales Channels USD Million (2015-2020)
  • Table 61. United Kingdom Troponin Diagnostic Tests, by Technology USD Million (2015-2020)
  • Table 62. Netherlands Troponin Diagnostic Tests, by Type USD Million (2015-2020)
  • Table 63. Netherlands Troponin Diagnostic Tests, by Sales Channels USD Million (2015-2020)
  • Table 64. Netherlands Troponin Diagnostic Tests, by Technology USD Million (2015-2020)
  • Table 65. Rest of Europe Troponin Diagnostic Tests, by Type USD Million (2015-2020)
  • Table 66. Rest of Europe Troponin Diagnostic Tests, by Sales Channels USD Million (2015-2020)
  • Table 67. Rest of Europe Troponin Diagnostic Tests, by Technology USD Million (2015-2020)
  • Table 68. MEA Troponin Diagnostic Tests, by Country USD Million (2015-2020)
  • Table 69. MEA Troponin Diagnostic Tests, by Type USD Million (2015-2020)
  • Table 70. MEA Troponin Diagnostic Tests, by Sales Channels USD Million (2015-2020)
  • Table 71. MEA Troponin Diagnostic Tests, by Technology USD Million (2015-2020)
  • Table 72. Middle East Troponin Diagnostic Tests, by Type USD Million (2015-2020)
  • Table 73. Middle East Troponin Diagnostic Tests, by Sales Channels USD Million (2015-2020)
  • Table 74. Middle East Troponin Diagnostic Tests, by Technology USD Million (2015-2020)
  • Table 75. Africa Troponin Diagnostic Tests, by Type USD Million (2015-2020)
  • Table 76. Africa Troponin Diagnostic Tests, by Sales Channels USD Million (2015-2020)
  • Table 77. Africa Troponin Diagnostic Tests, by Technology USD Million (2015-2020)
  • Table 78. North America Troponin Diagnostic Tests, by Country USD Million (2015-2020)
  • Table 79. North America Troponin Diagnostic Tests, by Type USD Million (2015-2020)
  • Table 80. North America Troponin Diagnostic Tests, by Sales Channels USD Million (2015-2020)
  • Table 81. North America Troponin Diagnostic Tests, by Technology USD Million (2015-2020)
  • Table 82. United States Troponin Diagnostic Tests, by Type USD Million (2015-2020)
  • Table 83. United States Troponin Diagnostic Tests, by Sales Channels USD Million (2015-2020)
  • Table 84. United States Troponin Diagnostic Tests, by Technology USD Million (2015-2020)
  • Table 85. Canada Troponin Diagnostic Tests, by Type USD Million (2015-2020)
  • Table 86. Canada Troponin Diagnostic Tests, by Sales Channels USD Million (2015-2020)
  • Table 87. Canada Troponin Diagnostic Tests, by Technology USD Million (2015-2020)
  • Table 88. Mexico Troponin Diagnostic Tests, by Type USD Million (2015-2020)
  • Table 89. Mexico Troponin Diagnostic Tests, by Sales Channels USD Million (2015-2020)
  • Table 90. Mexico Troponin Diagnostic Tests, by Technology USD Million (2015-2020)
  • Table 91. Troponin Diagnostic Tests: by Type(USD/Units)
  • Table 92. Company Basic Information, Sales Area and Its Competitors
  • Table 93. Company Basic Information, Sales Area and Its Competitors
  • Table 94. Company Basic Information, Sales Area and Its Competitors
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Troponin Diagnostic Tests: by Type(USD Million)
  • Table 103. Troponin Diagnostic Tests Troponin I ELISA Test , by Region USD Million (2021-2026)
  • Table 104. Troponin Diagnostic Tests Troponin Rapid test , by Region USD Million (2021-2026)
  • Table 105. Troponin Diagnostic Tests: by Sales Channels(USD Million)
  • Table 106. Troponin Diagnostic Tests Online Sales Channel {Company Website, E-Commerce Platform} , by Region USD Million (2021-2026)
  • Table 107. Troponin Diagnostic Tests Offline Sales Channels {Company store outlet, Hypermarket, and medical Stores} , by Region USD Million (2021-2026)
  • Table 108. Troponin Diagnostic Tests: by Technology(USD Million)
  • Table 109. Troponin Diagnostic Tests Qualitative Cardiac Troponin I Rapid Test (Qualitative cTnI) , by Region USD Million (2021-2026)
  • Table 110. Troponin Diagnostic Tests Semi-Quantitative Cardiac Troponin I Rapid Test (Semi-Quantitative cTnI) , by Region USD Million (2021-2026)
  • Table 111. Troponin Diagnostic Tests Quantitative Cardiac Troponin I Rapid Test (Quantitative cTnI) , by Region USD Million (2021-2026)
  • Table 112. South America Troponin Diagnostic Tests, by Country USD Million (2021-2026)
  • Table 113. South America Troponin Diagnostic Tests, by Type USD Million (2021-2026)
  • Table 114. South America Troponin Diagnostic Tests, by Sales Channels USD Million (2021-2026)
  • Table 115. South America Troponin Diagnostic Tests, by Technology USD Million (2021-2026)
  • Table 116. Brazil Troponin Diagnostic Tests, by Type USD Million (2021-2026)
  • Table 117. Brazil Troponin Diagnostic Tests, by Sales Channels USD Million (2021-2026)
  • Table 118. Brazil Troponin Diagnostic Tests, by Technology USD Million (2021-2026)
  • Table 119. Argentina Troponin Diagnostic Tests, by Type USD Million (2021-2026)
  • Table 120. Argentina Troponin Diagnostic Tests, by Sales Channels USD Million (2021-2026)
  • Table 121. Argentina Troponin Diagnostic Tests, by Technology USD Million (2021-2026)
  • Table 122. Rest of South America Troponin Diagnostic Tests, by Type USD Million (2021-2026)
  • Table 123. Rest of South America Troponin Diagnostic Tests, by Sales Channels USD Million (2021-2026)
  • Table 124. Rest of South America Troponin Diagnostic Tests, by Technology USD Million (2021-2026)
  • Table 125. Asia Pacific Troponin Diagnostic Tests, by Country USD Million (2021-2026)
  • Table 126. Asia Pacific Troponin Diagnostic Tests, by Type USD Million (2021-2026)
  • Table 127. Asia Pacific Troponin Diagnostic Tests, by Sales Channels USD Million (2021-2026)
  • Table 128. Asia Pacific Troponin Diagnostic Tests, by Technology USD Million (2021-2026)
  • Table 129. China Troponin Diagnostic Tests, by Type USD Million (2021-2026)
  • Table 130. China Troponin Diagnostic Tests, by Sales Channels USD Million (2021-2026)
  • Table 131. China Troponin Diagnostic Tests, by Technology USD Million (2021-2026)
  • Table 132. Japan Troponin Diagnostic Tests, by Type USD Million (2021-2026)
  • Table 133. Japan Troponin Diagnostic Tests, by Sales Channels USD Million (2021-2026)
  • Table 134. Japan Troponin Diagnostic Tests, by Technology USD Million (2021-2026)
  • Table 135. India Troponin Diagnostic Tests, by Type USD Million (2021-2026)
  • Table 136. India Troponin Diagnostic Tests, by Sales Channels USD Million (2021-2026)
  • Table 137. India Troponin Diagnostic Tests, by Technology USD Million (2021-2026)
  • Table 138. South Korea Troponin Diagnostic Tests, by Type USD Million (2021-2026)
  • Table 139. South Korea Troponin Diagnostic Tests, by Sales Channels USD Million (2021-2026)
  • Table 140. South Korea Troponin Diagnostic Tests, by Technology USD Million (2021-2026)
  • Table 141. Australia Troponin Diagnostic Tests, by Type USD Million (2021-2026)
  • Table 142. Australia Troponin Diagnostic Tests, by Sales Channels USD Million (2021-2026)
  • Table 143. Australia Troponin Diagnostic Tests, by Technology USD Million (2021-2026)
  • Table 144. Rest of Asia-Pacific Troponin Diagnostic Tests, by Type USD Million (2021-2026)
  • Table 145. Rest of Asia-Pacific Troponin Diagnostic Tests, by Sales Channels USD Million (2021-2026)
  • Table 146. Rest of Asia-Pacific Troponin Diagnostic Tests, by Technology USD Million (2021-2026)
  • Table 147. Europe Troponin Diagnostic Tests, by Country USD Million (2021-2026)
  • Table 148. Europe Troponin Diagnostic Tests, by Type USD Million (2021-2026)
  • Table 149. Europe Troponin Diagnostic Tests, by Sales Channels USD Million (2021-2026)
  • Table 150. Europe Troponin Diagnostic Tests, by Technology USD Million (2021-2026)
  • Table 151. Germany Troponin Diagnostic Tests, by Type USD Million (2021-2026)
  • Table 152. Germany Troponin Diagnostic Tests, by Sales Channels USD Million (2021-2026)
  • Table 153. Germany Troponin Diagnostic Tests, by Technology USD Million (2021-2026)
  • Table 154. France Troponin Diagnostic Tests, by Type USD Million (2021-2026)
  • Table 155. France Troponin Diagnostic Tests, by Sales Channels USD Million (2021-2026)
  • Table 156. France Troponin Diagnostic Tests, by Technology USD Million (2021-2026)
  • Table 157. Italy Troponin Diagnostic Tests, by Type USD Million (2021-2026)
  • Table 158. Italy Troponin Diagnostic Tests, by Sales Channels USD Million (2021-2026)
  • Table 159. Italy Troponin Diagnostic Tests, by Technology USD Million (2021-2026)
  • Table 160. United Kingdom Troponin Diagnostic Tests, by Type USD Million (2021-2026)
  • Table 161. United Kingdom Troponin Diagnostic Tests, by Sales Channels USD Million (2021-2026)
  • Table 162. United Kingdom Troponin Diagnostic Tests, by Technology USD Million (2021-2026)
  • Table 163. Netherlands Troponin Diagnostic Tests, by Type USD Million (2021-2026)
  • Table 164. Netherlands Troponin Diagnostic Tests, by Sales Channels USD Million (2021-2026)
  • Table 165. Netherlands Troponin Diagnostic Tests, by Technology USD Million (2021-2026)
  • Table 166. Rest of Europe Troponin Diagnostic Tests, by Type USD Million (2021-2026)
  • Table 167. Rest of Europe Troponin Diagnostic Tests, by Sales Channels USD Million (2021-2026)
  • Table 168. Rest of Europe Troponin Diagnostic Tests, by Technology USD Million (2021-2026)
  • Table 169. MEA Troponin Diagnostic Tests, by Country USD Million (2021-2026)
  • Table 170. MEA Troponin Diagnostic Tests, by Type USD Million (2021-2026)
  • Table 171. MEA Troponin Diagnostic Tests, by Sales Channels USD Million (2021-2026)
  • Table 172. MEA Troponin Diagnostic Tests, by Technology USD Million (2021-2026)
  • Table 173. Middle East Troponin Diagnostic Tests, by Type USD Million (2021-2026)
  • Table 174. Middle East Troponin Diagnostic Tests, by Sales Channels USD Million (2021-2026)
  • Table 175. Middle East Troponin Diagnostic Tests, by Technology USD Million (2021-2026)
  • Table 176. Africa Troponin Diagnostic Tests, by Type USD Million (2021-2026)
  • Table 177. Africa Troponin Diagnostic Tests, by Sales Channels USD Million (2021-2026)
  • Table 178. Africa Troponin Diagnostic Tests, by Technology USD Million (2021-2026)
  • Table 179. North America Troponin Diagnostic Tests, by Country USD Million (2021-2026)
  • Table 180. North America Troponin Diagnostic Tests, by Type USD Million (2021-2026)
  • Table 181. North America Troponin Diagnostic Tests, by Sales Channels USD Million (2021-2026)
  • Table 182. North America Troponin Diagnostic Tests, by Technology USD Million (2021-2026)
  • Table 183. United States Troponin Diagnostic Tests, by Type USD Million (2021-2026)
  • Table 184. United States Troponin Diagnostic Tests, by Sales Channels USD Million (2021-2026)
  • Table 185. United States Troponin Diagnostic Tests, by Technology USD Million (2021-2026)
  • Table 186. Canada Troponin Diagnostic Tests, by Type USD Million (2021-2026)
  • Table 187. Canada Troponin Diagnostic Tests, by Sales Channels USD Million (2021-2026)
  • Table 188. Canada Troponin Diagnostic Tests, by Technology USD Million (2021-2026)
  • Table 189. Mexico Troponin Diagnostic Tests, by Type USD Million (2021-2026)
  • Table 190. Mexico Troponin Diagnostic Tests, by Sales Channels USD Million (2021-2026)
  • Table 191. Mexico Troponin Diagnostic Tests, by Technology USD Million (2021-2026)
  • Table 192. Troponin Diagnostic Tests: by Type(USD/Units)
  • Table 193. Research Programs/Design for This Report
  • Table 194. Key Data Information from Secondary Sources
  • Table 195. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Troponin Diagnostic Tests: by Type USD Million (2015-2020)
  • Figure 5. Global Troponin Diagnostic Tests: by Sales Channels USD Million (2015-2020)
  • Figure 6. Global Troponin Diagnostic Tests: by Technology USD Million (2015-2020)
  • Figure 7. South America Troponin Diagnostic Tests Share (%), by Country
  • Figure 8. Asia Pacific Troponin Diagnostic Tests Share (%), by Country
  • Figure 9. Europe Troponin Diagnostic Tests Share (%), by Country
  • Figure 10. MEA Troponin Diagnostic Tests Share (%), by Country
  • Figure 11. North America Troponin Diagnostic Tests Share (%), by Country
  • Figure 12. Global Troponin Diagnostic Tests: by Type USD/Units (2015-2020)
  • Figure 13. Global Troponin Diagnostic Tests share by Players 2020 (%)
  • Figure 14. Global Troponin Diagnostic Tests share by Players (Top 3) 2020(%)
  • Figure 15. Global Troponin Diagnostic Tests share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Abbott Diagnostics, Inc. (United States.) Revenue, Net Income and Gross profit
  • Figure 18. Abbott Diagnostics, Inc. (United States.) Revenue: by Geography 2020
  • Figure 19. F. Hoffmann-La Roche Ltd (Switzerland) Revenue, Net Income and Gross profit
  • Figure 20. F. Hoffmann-La Roche Ltd (Switzerland) Revenue: by Geography 2020
  • Figure 21. BioMrieux SA (France) Revenue, Net Income and Gross profit
  • Figure 22. BioMrieux SA (France) Revenue: by Geography 2020
  • Figure 23. BG Medicine, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. BG Medicine, Inc. (United States) Revenue: by Geography 2020
  • Figure 25. Singulex, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Singulex, Inc. (United States) Revenue: by Geography 2020
  • Figure 27. Alere, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Alere, Inc. (United States) Revenue: by Geography 2020
  • Figure 29. Siemens Healthcare Diagnostics, Inc. (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Siemens Healthcare Diagnostics, Inc. (Germany) Revenue: by Geography 2020
  • Figure 31. Beckman Coulter, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Beckman Coulter, Inc. (United States) Revenue: by Geography 2020
  • Figure 33. LifeSign LLC (United States) Revenue, Net Income and Gross profit
  • Figure 34. LifeSign LLC (United States) Revenue: by Geography 2020
  • Figure 35. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 36. Danaher Corporation (United States) Revenue: by Geography 2020
  • Figure 37. Global Troponin Diagnostic Tests: by Type USD Million (2021-2026)
  • Figure 38. Global Troponin Diagnostic Tests: by Sales Channels USD Million (2021-2026)
  • Figure 39. Global Troponin Diagnostic Tests: by Technology USD Million (2021-2026)
  • Figure 40. South America Troponin Diagnostic Tests Share (%), by Country
  • Figure 41. Asia Pacific Troponin Diagnostic Tests Share (%), by Country
  • Figure 42. Europe Troponin Diagnostic Tests Share (%), by Country
  • Figure 43. MEA Troponin Diagnostic Tests Share (%), by Country
  • Figure 44. North America Troponin Diagnostic Tests Share (%), by Country
  • Figure 45. Global Troponin Diagnostic Tests: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • Abbott Diagnostics, Inc. (United States.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • BioMrieux SA (France)
  • BG Medicine, Inc. (United States)
  • Singulex, Inc. (United States)
  • Alere, Inc. (United States)
  • Siemens Healthcare Diagnostics, Inc. (Germany)
  • Beckman Coulter, Inc. (United States)
  • LifeSign LLC (United States)
  • Danaher Corporation (United States)
Additional players considered in the study are as follows:
Thermo Fisher Scientific, Inc. (United States) , Bio-Rad Laboratories, Inc. (United States) , Ortho-Clinical Diagnostics, Inc. (India)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation